HCT-1026. Treatment of septic shock treatment of urinary incontinence treatment of osteoporosis nitric oxide donor

Drugs of the Future

Volumn 24, Issue 8, 1999, Pages 858-861

  Burgaud, J L ^a   Benedini, F ^b   Robinson, E M ^a   Del Soldato, P ^a  

^a NicOx SA   (France)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; FLURBIPROFEN 4 NITROXYBUTYL ESTER; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLADDER CONTRACTION; BLOOD FLOW VELOCITY; DRUG ABSORPTION; DRUG CONFORMATION; DRUG SAFETY; HUMAN; HUMAN EXPERIMENT; NONHUMAN; NORMAL HUMAN; OSTEOPOROSIS; RAT; SEPTIC SHOCK; STOMACH BLOOD FLOW; STRUCTURE ACTIVITY RELATION; THROMBOCYTE AGGREGATION INHIBITION; URINE INCONTINENCE;

EID: 0032858309     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1999.024.08.545295     Document Type: Article

References (21)

1. Ignarro, L.J. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 1990, 30: 535-60.
2. Brown, G.C. Nitric oxide inhibition of cytochrome oxidase and mitochondrial respiration: Implications for inflammatory, neurodegenerative and ischaemic pathologies. Mol Cell Biochem 1997, 174: 189-92.
3. Moncada, S., Higgs, A. The L-arginine-nitric oxide pathway. N Engl J Med 1993, 329: 2002-12.
4. Zeiher, A.M. Endothelial vasodilator dysfunction: Pathogenetic link to myocardial ischaemia or epiphenomenon? Lancet 1996, 348: S10-2.
5. Moroi, M., Zhang, L., Yasuda, T., Virmani, R., Gold, H.K., Fishman, M.C., Huang, P.L. Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular responses to injury in mice. J Clin Invest 1998, 101: 1225-32.
6. Dimmeler, S., Haendeler, J., Nehls, M., Zeiher, A.M. Suppression of apoptosis by nitric oxide via inhibition of ICE-like and CPP32-like proteases. J Exp Med 1997, 185: 601-8.
7. Dimmeler, S., Hermann, C., Zeiher, A.M. Apoptosis of endothelial cells. Contribution to the pathophysiology of atherosclerosis. Eur Cytokine Netw 1998, 9: 697-8.
8. Dimmeler, S., Rippmann, V., Weiland, U., Haendeler, J., Zeiher, A.M. Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res 1997, 81: 970-6.
9. Cooke, J.P., Singer, A.H., Tsao, P., Zear, P., Rowan, R.A., Billingham, M.E. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992, 90: 1168-72.
10. Rudic, R.D., Shesely, E.G., Maeda, N., Smithies, O., Segal, S.S., Sessa, W.C. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 1998, 101: 731-6.
11. Wallace, J.L., Cirino, G., McKnight, G.W., Elliott, S.N. Reduction of gastrointestinal injury in acute endotoxic shock by flurbiprofen nitroxybutylester. Eur J Pharmacol 1995, 280: 63-8.
12. Hauss-Wegrzyniak, B., Willard, L.B., Del Soldato, P., Pepeu, G., Wenk, G. Peripheral administration of novel anti-inflammatories can attenuate the effects of chronic inflammation within the CNS. Brain Res 1999, 815: 36-43.
13. Hauss-Wegrzyniak, B., Vraniak, P., Wenk, G. The effects of a novel NSAID upon chronic neuroinflammation are age dependent. 1999; in press.
14. Cystometrographic studies in rats after bladder infusion with saline and acetic acid. Internal report, October 10, 1997.
15. Cirino, G., Wheeler-Jones, C.P., Wallace, J.L., Del Soldato, P., Baydoun, A.R. Inhibition of inducible nitric oxide synthase expression by novel nonsteroidal anti-inflammatory derivatives with gastrointestinal-sparing properties. Br J Pharmacol 1996, 117: 1421-6.
16. Van't Hof, R.J., Del Soldato, P., Ralston, S.H. NO-NSAIDs: A novel class of osteoclast inhibitors. Mediat Inflamm 1999, 8(Suppl 1): Abst S128.
17. Data on file. RBM SpA. Exp. No 960093, July 18, 1996.
18. Data on file. RBM SpA. Exp. No 960088, December 4, 1996.
19. Report of Clinical Trial HCT-1026/01/98, Draft of Report.
20. Report of Clinical Trial HCT-1026/01/96, June 15, 1999.
21. Donnelly, M.T., Stack, W.A., Courtauld, E.M., Garlick, N., Del Soldato, P., Hawkey, C.J. Nitric oxide donating flurbiprofen (HCT-1026) causes less endoscopic damage in healthy volunteers than flurbiprofen. Gastroenterology 1998, 144: Abst 107.